GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Delta-Fly Pharma Inc (TSE:4598) » Definitions » Gross-Profit-to-Asset %

Delta-Fly Pharma (TSE:4598) Gross-Profit-to-Asset % : 0.00% (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Delta-Fly Pharma Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Delta-Fly Pharma's annualized Gross Profit for the quarter that ended in Dec. 2023 was 円0.00 Mil. Delta-Fly Pharma's average Total Assets over the quarter that ended in Dec. 2023 was 円1,135.47 Mil. Therefore, Delta-Fly Pharma's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 0.00%.


Delta-Fly Pharma Gross-Profit-to-Asset % Historical Data

The historical data trend for Delta-Fly Pharma's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Delta-Fly Pharma Gross-Profit-to-Asset % Chart

Delta-Fly Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial - 3.49 13.88 17.21 -

Delta-Fly Pharma Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Delta-Fly Pharma's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Delta-Fly Pharma's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Delta-Fly Pharma's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Delta-Fly Pharma's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Delta-Fly Pharma's Gross-Profit-to-Asset % falls into.



Delta-Fly Pharma Gross-Profit-to-Asset % Calculation

Delta-Fly Pharma's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Mar. 2023 )/( (Total Assets (A: Mar. 2022 )+Total Assets (A: Mar. 2023 ))/ count )
=0/( (1324.352+906.817)/ 2 )
=0/1115.5845
=0.00 %

Delta-Fly Pharma's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=0/( (490.779+1780.153)/ 2 )
=0/1135.466
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Delta-Fly Pharma Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Delta-Fly Pharma's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Delta-Fly Pharma (TSE:4598) Business Description

Traded in Other Exchanges
N/A
Address
Miyajima Kinno 37-5, Tokushima Prefecture, Kawauchi Town, Tokushima, JPN, 771-0116
Delta-Fly Pharma Inc is a Japan-based company mainly engaged in the discovery and development of gentle anti-cancer agents with module technology.

Delta-Fly Pharma (TSE:4598) Headlines

No Headlines